All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WJ1778 | Anti-NUCB2 (mab9) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | mab9 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1779 | Anti-NUCB2 (NAP37) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | NAP37 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1780 | Anti-NUCB2 (NAP39) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | NAP39 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1781 | Anti-NUCB2 (NAP40-2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | NAP40-2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1782 | Anti-NUCB2 (CBWJN-0735) h(41BB-CD3ζ) CAR, pCDCAR1 | Rat | CBWJN-0735 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1783 | Anti-NUCB2 (NET1) h(41BB-CD3ζ) CAR, pCDCAR1 | NET1 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ4070 | Anti-NUCB2 (mab9) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | mab9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4071 | Anti-NUCB2 (NAP37) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | NAP37 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4072 | Anti-NUCB2 (NAP39) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | NAP39 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4073 | Anti-NUCB2 (NAP40-2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | NAP40-2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4074 | Anti-NUCB2 (CBWJN-0735) h(CD28-CD3ζ) CAR, pCDCAR1 | Rat | CBWJN-0735 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4075 | Anti-NUCB2 (NET1) h(CD28-CD3ζ) CAR, pCDCAR1 | NET1 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION